Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Deal Watch: Xencor Adds New Bispecific Partner In Agreement With Genentech

Executive Summary

Genentech will pay $120m up front to co-develop Xencor’s preclinical IL-15 candidate; deal also includes IL-15 R&D. Taiho licenses lung cancer candidate to Cullinan; Celgene and Triphase partner again.

Advertisement

Related Content

GSK Makes I-O Move With Merck KGaA Deal Worth Up To €3.7bn
Simbec-Orion MBO Underpins Build And Buy Strategy
Medicxi Links With Sosei Heptares For Orexin Agonist Vehicles
Bristol Approached Celgene Nearly Two Years Ago, Got A Better Deal Later
MeiraGTx Signs J&J To Develop Gene Therapies For Rare Retinal Diseases
Voyager Nabs Neurocrine As Partner In CNS Gene Therapy
Deal Watch: Celgene Makes Alliances With Kyn, Obsidian After Bristol Buyout
Deal Watch: Sanofi Retains Options To Two Bispecifics While Exiting Antibody Pact With Regeneron
Cullinan To Search For Oncology’s Diamonds In The Rough
Fortress Biotech: A Drug Financing Experiment Expands

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

SC124620

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel